- Winter Brings Rise in Carbon Monoxide Danger: Stay Safe
- Wind Power Is Bringing Americans Real Health Benefits
- Scientists May Be Closer to Effective HIV Vaccine
- AHA News: After Cardiac Arrest at College Basketball Game, He’s Ready to Cheer Again
- 988 Mental Health Hotline Back in Business After Daylong Outage
- Seizures Seem Tied to Faster Decline in People With Dementia
- Cost of Epilepsy Meds Continues to Soar
- ‘Tumor Progressing,’ ‘Positive Findings’: Patients Often Confused by Medical Jargon
- Few Americans Understand Alcohol’s Impact on Cancer Risk: Survey
- Cases of Meth-Linked Heart Failure Are Spreading Worldwide
Generic Aciphex Approved to Treat Chronic Heartburn
FRIDAY, Nov. 8The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.
License to produce generic rabeprazole was granted to Dr. Reddy’s Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.
The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.
More information
To learn more about GERD, visit Medline Plus.
Source: HealthDay
Copyright © 2022 HealthDay. All rights reserved.
Related
-
The ‘Great Resignation’ Is Taking a Toll on U.S. Health CareThe nationwide shortage of health care professionals — a...
- December 1, 2022
-
Many U.S. Seniors Get Needless, Pricey Cervical Cancer ScreeningsResearchers warn that high rates of cervical cancer screening...
- November 30, 2022
-
High Deductibles Keep Some Women From Follow-Up After Troubling MammogramOut-of-pocket costs may make as many as 1 in...
- November 29, 2022
-
How Benign Are ‘Benign’ Breast Findings? Study Finds Link to Higher Cancer RiskMany women feel a lump in their breast or...
- November 22, 2022
